Literature DB >> 20692040

Risk of placental abruption in relation to maternal depressive, anxiety and stress symptoms.

Nicole C de Paz1, Sixto E Sanchez, Luis E Huaman, Guillermo Diez Chang, Percy N Pacora, Pedro J Garcia, Cande V Ananth, Chungfang Qiu, Michelle A Williams.   

Abstract

BACKGROUND: Little is known about the influence of psychiatric factors on the etiology of placental abruption (PA), an obstetrical condition that complicates 1-2% of pregnancies. We examined the risk of PA in relation to maternal psychiatric symptoms during pregnancy.
METHODS: This case-control study included 373 PA cases and 368 controls delivered at five medical centers in Lima, Peru. Depressive, anxiety and stress symptoms were assessed using the Patient Health Questionnaire (PHQ-9) and the Depression Anxiety Stress Scales (DASS-21). Multivariable logistic regression models were fit to calculate odds ratios (aOR) and 95% confidence intervals (CI) adjusted for confounders.
RESULTS: Depressive symptoms of increasing severity (using the DASS depression subscale) was associated with PA (p for trend=0.02). Compared with women with no depressive symptoms, the aOR (95%CI) for PA associated with each level of severity of depression symptoms based on the DASS assessment were as follows: mild 1.84 (0.91-3.74); moderate 1.25 (0.67-2.33); and severe 4.68 (0.98-22.4). The corresponding ORs for mild, moderate, and moderately severe depressive symptoms based on the PHQ assessment were 1.10 (0.79-1.54), 3.31 (1.45-7.57), and 5.01 (1.06-23.6), respectively. A positive gradient was observed for the odds of PA with severity of anxiety (p for trend=0.002) and stress symptoms (p for trend=0.002). LIMITATIONS: These cross-sectionally collected data may be subject to recall bias.
CONCLUSIONS: Maternal psychiatric disorders may be associated with an increased occurrence of AP. Larger studies that allow for more precise evaluations of maternal psychiatric health in relation to PA risk are warranted. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2010        PMID: 20692040      PMCID: PMC2994998          DOI: 10.1016/j.jad.2010.07.024

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  33 in total

Review 1.  Placental abruption.

Authors:  Yinka Oyelese; Cande V Ananth
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

Review 2.  Genetic risk factors for placental abruption: a HuGE review and meta-analysis.

Authors:  Nikos Zdoukopoulos; Elias Zintzaras
Journal:  Epidemiology       Date:  2008-03       Impact factor: 4.822

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Panic attack-associated placental abruption: a case report.

Authors:  L S Cohen; J F Rosenbaum; V L Heller
Journal:  J Clin Psychiatry       Date:  1989-07       Impact factor: 4.384

Review 5.  Neurotransmitter alterations in PTSD: catecholamines and serotonin.

Authors:  S M Southwick; S Paige; C A Morgan; J D Bremner; J H Krystal; D S Charney
Journal:  Semin Clin Neuropsychiatry       Date:  1999-10

6.  Histologic evidence of inflammation and risk of placental abruption.

Authors:  Carl A Nath; Cande V Ananth; John C Smulian; Susan Shen-Schwarz; Lillian Kaminsky
Journal:  Am J Obstet Gynecol       Date:  2007-09       Impact factor: 8.661

7.  Hypercoagulability in working men and women with high levels of panic-like anxiety.

Authors:  Roland von Känel; Brigitte M Kudielka; Renate Schulze; Marie-Louise Gander; Joachim E Fischer
Journal:  Psychother Psychosom       Date:  2004 Nov-Dec       Impact factor: 17.659

8.  Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction.

Authors:  S K Agarwal; G D Marshall
Journal:  J Interferon Cytokine Res       Date:  1998-12       Impact factor: 2.607

Review 9.  Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?

Authors:  R von Känel
Journal:  Acta Psychiatr Scand       Date:  2004-09       Impact factor: 6.392

10.  Maternal depressive symptoms, depression, and psychiatric medication use in relation to risk of preterm delivery.

Authors:  Amelia R Gavin; Claudia Holzman; Kristine Siefert; Yan Tian
Journal:  Womens Health Issues       Date:  2009 Sep-Oct
View more
  23 in total

1.  Comparative performance of Patient Health Questionnaire-9 and Edinburgh Postnatal Depression Scale for screening antepartum depression.

Authors:  Qiuyue Zhong; Bizu Gelaye; Marta Rondon; Sixto E Sánchez; Pedro J García; Elena Sánchez; Yasmin V Barrios; Gregory E Simon; David C Henderson; Swee May Cripe; Michelle A Williams
Journal:  J Affect Disord       Date:  2014-03-26       Impact factor: 4.839

2.  Depression, anxiety and stress among pregnant migraineurs in a pacific-northwest cohort.

Authors:  Olivia R Orta; Bizu Gelaye; Chungfang Qiu; Lee Stoner; Michelle A Williams
Journal:  J Affect Disord       Date:  2014-10-22       Impact factor: 4.839

3.  Now what? Effects of on-site assessment on treatment entry after perinatal depression screening.

Authors:  Laura J Miller; Andrea McGlynn; Katherine Suberlak; Leah H Rubin; Michelle Miller; Vesna Pirec
Journal:  J Womens Health (Larchmt)       Date:  2012-09-20       Impact factor: 2.681

Review 4.  Effects of prenatal stress on pregnancy and human development: mechanisms and pathways.

Authors:  Mary E Coussons-Read
Journal:  Obstet Med       Date:  2013-05-03

5.  Placental telomere length and risk of placental abruption.

Authors:  Tsegaselassie Workalemahu; Daniel A Enquobahrie; Ermias Yohannes; Sixto E Sanchez; Bizu Gelaye; Chunfang Qiu; Michelle A Williams
Journal:  J Matern Fetal Neonatal Med       Date:  2015-11-26

6.  Risk of spontaneous preterm birth in relation to maternal depressive, anxiety, and stress symptoms.

Authors:  Sixto E Sanchez; Gabriella C Puente; Guillermo Atencio; Chungfang Qiu; David Yanez; Bizu Gelaye; Michelle A Williams
Journal:  J Reprod Med       Date:  2013 Jan-Feb       Impact factor: 0.142

7.  Association of serum vitamin D with symptoms of depression and anxiety in early pregnancy.

Authors:  Jonathan Y Huang; Dodie Arnold; Chun-Fang Qiu; Raymond S Miller; Michelle A Williams; Daniel A Enquobahrie
Journal:  J Womens Health (Larchmt)       Date:  2014-06-11       Impact factor: 2.681

Review 8.  History of childhood sexual abuse and risk of prenatal and postpartum depression or depressive symptoms: an epidemiologic review.

Authors:  Adaeze C Wosu; Bizu Gelaye; Michelle A Williams
Journal:  Arch Womens Ment Health       Date:  2015-05-10       Impact factor: 3.633

Review 9.  Obesity and mental disorders during pregnancy and postpartum: a systematic review and meta-analysis.

Authors:  Emma Molyneaux; Lucilla Poston; Sarah Ashurst-Williams; Louise M Howard
Journal:  Obstet Gynecol       Date:  2014-04       Impact factor: 7.661

10.  Trajectories of antenatal depression and adverse pregnancy outcomes.

Authors:  Emily S Miller; George R Saade; Hyagriv N Simhan; Catherine Monk; David M Haas; Robert M Silver; Brian M Mercer; Samuel Parry; Deborah A Wing; Uma M Reddy; William A Grobman
Journal:  Am J Obstet Gynecol       Date:  2021-07-17       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.